These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37974274)

  • 1. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
    Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
    Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
    Zhou X; Wang W; Zhou C; Zhu J; Ding W; Chen M; Chen K; Shi Y; Chen X; Kong FM; Yang H
    Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
    Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
    Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Lu J; Ma Y; Chen J; Wang L; Zhang G; Zhao M; Yin Y
    J Radiat Res; 2014 Jan; 55(1):97-104. PubMed ID: 23728319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
    Niu X; Chang X; Gao Y; Hu C; Kong L
    Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma.
    Lin C; Lu Q; Chen Y; Chen X; Huang Y; Zhong H; Peng X; Hu C; Chen B; Lin S; Zong J
    Sci Rep; 2024 Aug; 14(1):17887. PubMed ID: 39095403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.
    Ou X; Yan W; Huang Y; He X; Ying H; Lu X; Zhu H; Wu B; Wang J; Hu C
    Radiat Oncol; 2023 Mar; 18(1):55. PubMed ID: 36944958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Ng WT; Lee MC; Hung WM; Choi CW; Lee KC; Chan OS; Lee AW
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):420-8. PubMed ID: 20452132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
    Zhao L; Wan Q; Zhou Y; Deng X; Xie C; Wu S
    Radiother Oncol; 2011 Jan; 98(1):23-7. PubMed ID: 21040992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Orlandi E; Tomatis S; Potepan P; Bossi P; Mongioj V; Carrara M; Palazzi M; Franceschini M; Bergamini C; Locati L; Iannacone E; Guzzo M; Ibba T; Crippa F; Licitra L; Pignoli E; Fallai C
    Future Oncol; 2013 Jan; 9(1):103-14. PubMed ID: 23252567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
    Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
    BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy reduces target volume drift in patients with locoregionally advanced nasopharyngeal carcinoma undergoing adaptive intensity-modulated radiotherapy: a retrospective cohort study.
    Yan D; Yin X; Wang L; Huang L; Tang Q; Cheng K; Yan S
    Quant Imaging Med Surg; 2023 Mar; 13(3):1779-1791. PubMed ID: 36915305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y; Gao Y; Yang G; Lang J
    Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
    Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
    Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.